Residual antimicrobial effect of chlorhexidine digluconate and octenidine dihydrochloride on reconstructed human epidermis

Skin Pharmacology and Physiology

Volumn 27, Issue 1, 2013, Pages 1-8

  Muller G ^a   Langer, J ^b   Siebert, J ^c   Kramer, A ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c SCHÜLKE AND MAYR GMBH   (Germany)

Author keywords

Antiseptics; Chlorhexidine digluconate; Octenidine dihydrochloride; Pseudomonas aeruginosa; Reconstructed human epidermis; Residual antimicrobial effect; Staphylococcus aureus

Indexed keywords

CHLORHEXIDINE GLUCONATE; DISINFECTANT AGENT; OCTENIDINE DIHYDROCHLORIDE; UNCLASSIFIED DRUG; OCTENIDINE;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STRATUM CORNEUM; ADULT; BACTERIAL GROWTH; CELL VIABILITY; COLONY FORMING UNIT; HUMAN CELL; KERATINOCYTE;

ANTI-INFECTIVE AGENTS, LOCAL; BACTERIAL LOAD; CELL SURVIVAL; CELLS, CULTURED; CHLORHEXIDINE; EPIDERMIS; HUMANS; KERATINOCYTES; PSEUDOMONAS AERUGINOSA; PYRIDINES; STAPHYLOCOCCUS AUREUS; TISSUE CULTURE TECHNIQUES;

EID: 84880416855     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000350172     Document Type: Article

References (36)

1. Garcia N, Doucet O, Bayer M, Fouchard D, Zastrow L, Marty JP: Characterization of the barrier function in a reconstituted human epidermis cultivated in chemically defined medium. Int J Cosmetic Sci 2002; 24: 25-34.
2. Barbotteau Y, Gontier E, Barberet P, Cappadoro M, De Wever B, Habchi C, Incerti S, Mavon A, Moretto P, Pouthier T, Smith RW, Ynsa MD: Reconstructed human epidermis: a model to study the barrier function. Nucl Instr Meth Phys Res B 2005; 231: 286-291.
3. Netzlaff F, Kaca M, Bock U, Haltner-Ukomadu E, Meiers P, Lehr C-M, Schaefer UF: Permeability of the reconstructed human epidermis model Episkin ® in comparison to various human skin preparations. Eur J Pharm Biopharm 2007; 66: 127-134.
4. Schäfer-Korting M, Bock U, Gamer A, Haberland A, Haltner-Ukomado E, Kaca M, Kamp H, Kietzmann M, Korting HC, Krächter H-U, Lehr C-M, Liebsch M, Mehling A, Netzlaff F, Niedorf F, Rübbelke MK, Schäfer U, Schmidt E, Schreiber S, Schröder K-R, Spielmann H, Vuia A: Reconstructed human epidermis for skin absorption testing: results of the German prevalidation study. ATLA 2006; 34: 283-294.
5. Schreiber S, Mahmoud A, Vuia A, Rübbelke MK, Schmidt E, Schaller M, Kandarova H, Haberland A, Schäfer UF, Bock U, Korting HC, Liebsch M, Schäfer-Korting M: Reconstructed epidermis versus human and animal skin in skin absorption studies. Toxicol in Vitro 2005; 19: 813-822.
6. Pham M-A, Magdalou JM, Siest G, Lenoir M-C, Bernard BA, Jamoulle J-C, Shroot B: Reconstituted epidermis: a novel model for the study of drug metabolism in human epidermis. J Invest Dermatol 1990; 94: 749-752.
7. Faller C, Bracher M, Dami N, Roguet R: Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics. Toxicol in Vitro 2002; 16: 557-572.
8. Kandarova H, Hayden P, Klausner M, Kubilius J, Sheasgreen J: An in vitro skin irritation test (SIT) using the EpiDerm reconstructed human epidermal (RHE) model. J Vis Exp 2009; 29: 1366.
9. Kidd DA, Johnson M, Clements J: Development of an in vitro corrosion/irritation prediction assay using EpiDerm TM skin model. Toxicol in Vitro 2007; 21: 1292-1297.
10. Tornier C, Rosdy M, Maibach HI: In vitro skin irritation testing on reconstituted human epidermis: reproducibility for 50 chemicals tested with two protocols. Toxicol in Vitro 2006; 20: 401-416.
11. Hoffmann J, Heisler E, Karpinski S, Losse J, Thomas D, Siefken W, Ahr H-J, Vohr H-W, Fuchs HW: Epidermal-Skin-Test 1,000 (EST-1,000)-a new reconstructed epidermis for in vitro skin corrosivity testing. Toxicol in Vitro 2005; 19: 925-929.
12. El Ghalazouri A, Siamari R, Willemze R, Ponec M: Leiden reconstructed human epidermal model as a tool for the evaluation of the skin corrosion and irritation potential according to the ECVAM guidelines. Toxicol in Vitro 2008; 22: 1311-1320.
13. Nagasawa M, Hayashi H, Nakayoshi T: In vitro evaluation of skin sensitivity of povidoneiodine and other antiseptics using a three-dimensional human skin model. Dermatology 2002; 204: 109-113.
14. Poumay Y, Dupont F, Marcoux S, Leclercq-Smekens M, Herin M, Coquette A: A simple reconstructed human epidermis: preparation of the culture model and utilization in in vitro studies. Arch Dermatol Res 2004; 296: 203-211.
15. Kandarova H, Liebsch M, Spielmann H, Genschow E, Schmidt E, Traue D, Guest R, Whittingham A, Warren N, Gamer AO, Remmele M, Kaufmann T, Wittmer E, De Wever B, Rosdy M: Assessment of the epidermis model SkinEthic RHE for in vitro skin corrosion testing of chemicals according to new OECD TG 431. Toxicol in Vitro 2006; 20: 547-559.
16. Netzlaff F, Lehr C-M, Wertz PW, Schaefer UF: The human epidermis models EpiSkin ® , SkinEthic ® , EpiDerm ® : an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur J Pharm Biopharm 2005; 60: 167-178.
17. McDonell G, Russell AD: Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999; 12: 147-179.
18. Wade JJ, Casewell MW: The evaluation of residual antimicrobial activity on hands and its clinical relevance. J Hosp Infect 1991; 18: 23-28.
19. Wickett RR, Visscher MO: Structure and function of the epidermal barrier. Am J Infect Control 2006; 34:S98-S110.
20. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Meth 1983; 65: 55-63.
21. OECD: In vitro skin corrosion: human skin model test. OECD guideline for the testing of chemicals No 431. 2004.
22. OECD: In vitro skin irritation: reconstructed human epidermis test model. OECD guideline for the testing of chemicals No 439. 2010.
23. Kramer A, Assadian O, Müller G, Reichwagen S, Widulla H, Heldt P, Nürnberg W: Octenidine, Chlorhexidine, Iodine and Iodophores. Stuttgart, Thieme, 2008.
24. Gilbert P, Moore LE: Cationic antiseptics: diversity of action under a common epithet. J Appl Microbiol 2005; 99: 703-715.
25. Smylie HG, Logie JR, Smith G: From Phisohex to Hibiscrub. Br Med J 1973; 4: 586-589.
26. Peterson AF, Rosenberg A, Alatary SD: Comparative evaluation of surgical scrub preparations. Surg Gynecol Obstet 1978; 146: 63-65.
27. Aly R, Maibach HI: Comparative antimicrobial efficacy of a 2-min surgical scrub with chlorhexidine gluconate, povidone-iodine, and chloroxylenol sponge-brushes. Am J Infect Control 1988; 16: 173-177.
28. Eigner U, Behrens U: In vivo method for testing the long-term efficacy of a skin disinfectant. Hyg Med 1985; 104: 75-78.
29. Müller G, Kramer A, Siebert J: Interaction of octenidine and chlorhexidine with mammalian cells and the resulting microbicidal effect (remanence) of the combinations. GMS Krankenhaushyg Interdiszip 2007; 2: 46.
30. Sedlock DM, Bailey DM: Microbicidal activity of octenidine hydrochloride, a new alkanediylbis (pyridine) germicidal agent. Antimicrob Agents Chemother 1985; 28: 786-790.
31. Koburger T, Hübner N-O, Braun M, Siebert J, Kramer A: Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. J Antimicrob Chemother 2010; 65: 1712-1719.
32. Kügler R, Bouloussa O, Rondelez F: Evidence of a charge-density threshold for optimum efficiency of biocidal cationic surfaces. Microbiology 2005; 151: 1341-1348.
33. Murata H, Koepsel RR, Matyjaszewski K, Russell AJ: Permanent, non-leaching antibacterial surfaces. 2. How high density cationic surfaces kill bacterial cells. Biomaterials 2007; 28: 4870-4879.
34. Karpanen TJ, Worthington T, Conway BR, Hilton AC, Elliott TSJ, Lambert PA: Penetration of chlorhexidine into skin. Antimicrob Agents Chemother 2008; 52: 3633-3636.
35. Stahl J, Braun M, Siebert J, Kietzmann M: The percutaneous permeation of a combination of 0.1% octenidine dihydrochloride and 2% 2-phenoxyethanol (Octenisept ® ) through skin of different species in vitro. BMC Vet Res 2011; 7: 44.
36. Müller G, Kramer A: Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrob Chemother 2008; 61: 1281-1287.